Shi Q, Wang CL, Zhang H, Chen C, Zhang X, Chang X-L
This type affects roughly 96% of all patients with DS and involves a complete extra copy of chromosome 21
Seeing these patterns of lower use of emergency care and lower use of drugs to stop migraines or trying additional drugs to prevent migraines among people taking GLP-1 drugs for other conditions suggests that these therapies may help stabilize the disease burden in ways that we havent fully appreciated yet
A double-blind, placebo-controlled, clinical trial in 47 patients with vitiligo showed that the administration of GB 40 mg three times daily could halt disease progression and cause repigmentation of most perifacial vitiligo lesions [108]
[16] [15] Most events are mild to moderate and typically diminish over time
Whilst GLP-1 medications do not directly cause vision problems in most patients, anyone taking these treatments should remain vigilant about eye health, particularly if they have diabetes